Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 334 | 314 | 312 | 884 | 2,343 |
| Cost of Goods | 130 | 2,284 | 157 | 136 | 1,517 |
| Gross Profit | 204 | -1,970 | 155 | 748 | 826 |
| Operating Expenses | 3,484 | 3,526 | 3,036 | 3,955 | 4,370 |
| Operating Income | -3,150 | -5,212 | -2,724 | -3,071 | -3,027 |
| Interest Expense | 3,884 | 394 | 453 | 628 | 458 |
| Other Income | 1,128 | 267 | 449 | 171 | 1,582 |
| Pre-tax Income | -5,906 | -5,339 | -2,728 | -3,528 | -1,903 |
| Income Tax | -4 | -1 | 1 | 1 | N/A |
| Net Income Continuous | -5,910 | -4,186 | -2,729 | -4,681 | -1,903 |
| Net Income Discontinuous | 14 | -1,168 | 7,926 | N/A | -1,086 |
| Minority Interests | -26 | -44 | 1,323 | -219 | -402 |
| Net Income | $-5,870 | $-5,310 | $3,874 | $-4,462 | $-2,587 |
| EPS Basic Total Ops | -0.60 | -0.53 | 0.44 | -0.62 | -0.38 |
| EPS Basic Continuous Ops | -0.61 | -0.47 | -0.31 | -0.65 | -0.28 |
| EPS Basic Discontinuous Ops | 0.00 | -0.03 | 0.91 | N/A | -0.16 |
| EPS Diluted Total Ops | -0.60 | -0.53 | 0.44 | -0.62 | -0.38 |
| EPS Diluted Continuous Ops | -0.61 | -0.47 | -0.31 | -0.65 | -0.28 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.03 | 0.91 | N/A | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.61 | -0.31 | -0.62 | -0.38 |
| EBITDA(a) | $-1,232 | $-4,615 | $-2,110 | $-2,451 | $-2,391 |